Intuitive Surgical, Inc. $ISRG Holdings Raised by Swiss Life Asset Management Ltd

Swiss Life Asset Management Ltd lifted its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 7.7% in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 67,483 shares of the medical equipment provider’s stock after purchasing an additional 4,824 shares during the quarter. Swiss Life Asset Management Ltd’s holdings in Intuitive Surgical were worth $30,180,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds have also recently bought and sold shares of the stock. Kilter Group LLC purchased a new position in shares of Intuitive Surgical in the second quarter worth approximately $27,000. Greykasell Wealth Strategies Inc. purchased a new stake in shares of Intuitive Surgical in the 3rd quarter valued at approximately $27,000. Caitlin John LLC acquired a new position in Intuitive Surgical in the 3rd quarter worth approximately $30,000. KERR FINANCIAL PLANNING Corp purchased a new position in Intuitive Surgical during the 3rd quarter worth approximately $33,000. Finally, Guerra Advisors Inc purchased a new position in Intuitive Surgical during the 3rd quarter worth approximately $37,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Price Performance

Shares of NASDAQ ISRG opened at $477.73 on Thursday. Intuitive Surgical, Inc. has a one year low of $425.00 and a one year high of $603.88. The business’s 50-day moving average price is $507.10 and its two-hundred day moving average price is $512.85. The company has a market capitalization of $169.66 billion, a P/E ratio of 60.55, a price-to-earnings-growth ratio of 3.72 and a beta of 1.66.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.27 by $0.26. The business had revenue of $2.87 billion during the quarter, compared to analyst estimates of $2.72 billion. Intuitive Surgical had a return on equity of 15.06% and a net margin of 28.38%.The firm’s revenue was up 18.8% on a year-over-year basis. During the same period in the previous year, the company earned $2.21 EPS. On average, equities analysts anticipate that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Analyst Ratings Changes

ISRG has been the subject of a number of research analyst reports. Barclays set a $712.00 target price on Intuitive Surgical and gave the company an “overweight” rating in a report on Monday, January 26th. BTIG Research reissued a “buy” rating and set a $616.00 price target on shares of Intuitive Surgical in a research report on Friday, January 23rd. TD Cowen raised Intuitive Surgical to a “strong-buy” rating in a research note on Tuesday, January 27th. The Goldman Sachs Group restated a “buy” rating and set a $714.00 price objective on shares of Intuitive Surgical in a research report on Friday, January 9th. Finally, Wall Street Zen downgraded Intuitive Surgical from a “buy” rating to a “hold” rating in a report on Saturday, February 7th. Two investment analysts have rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating, six have assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $614.95.

Insider Activity

In other news, SVP Mark Brosius sold 2,362 shares of the stock in a transaction on Wednesday, March 4th. The shares were sold at an average price of $498.68, for a total transaction of $1,177,882.16. Following the transaction, the senior vice president owned 3,554 shares in the company, valued at $1,772,308.72. This represents a 39.93% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, EVP Myriam Curet sold 421 shares of the firm’s stock in a transaction on Wednesday, February 11th. The shares were sold at an average price of $494.96, for a total transaction of $208,378.16. Following the transaction, the executive vice president owned 409 shares in the company, valued at $202,438.64. This represents a 50.72% decrease in their position. The SEC filing for this sale provides additional information. In the last 90 days, insiders have sold 32,943 shares of company stock valued at $17,279,568. 0.70% of the stock is currently owned by company insiders.

Intuitive Surgical News Summary

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Company fundamentals and market positioning — Intuitive reported a strong January quarter (beats on revenue and EPS, ~19% revenue growth year‑over‑year) and is pursuing lower‑cost da Vinci systems to target fast‑growing ambulatory surgery centers, which could expand procedure volume outside hospitals over time. No external link
• Neutral Sentiment: Sector and competitive news with limited direct impact — other medtech product launches and approvals in the broader ecosystem (e.g., Merit Medical’s new esophageal stent) are being reported but do not directly displace Intuitive’s robotic surgery franchise. MMSI Launches Resilience TTS Stent for Esophageal Fistulas, Strictures
• Negative Sentiment: FDA regulatory flag — Intuitive was flagged by the FDA over a medical device issue, which raises near‑term regulatory and operational risk concerns; such notices can prompt customer caution, warranty/repair costs, or increased oversight that pressure sentiment. Intuitive Surgical flagged by FDA over medical device issue
• Negative Sentiment: Analyst outlook softened — UBS cut its price target from $570 to $550 and set a “neutral” rating, reducing near‑term upside expectations and likely contributing to selling pressure; the new target still implies some upside versus current levels but reflects more cautious sentiment. Intuitive Surgical (NASDAQ:ISRG) Price Target Lowered to $550.00 at UBS Group

Intuitive Surgical Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.